EUVIMEDEUVIMED entdecken
Open Access

Telomere length and oxidative stress in small cell lung cancer patients changes through chemotherapy cycles compared to healthy controls

Azra Guzonjić, Dragana Jovanović, Ivana Simić, Vesna Ćeriman Krstić, Natalija Samardzić, Barbara Ostanek, Janja Marc, Miron Sopić, Jelena Kotur Stevuljević

Biochemia medica · 2025

DOI: 10.11613/bm.2025.020705 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemia medica, 2025. Verfasst von Azra Guzonjić und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department for Medical Biochemistry, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia. Hauptthemen laut MEDLINE: Oxidative Stress, Lung Neoplasms, Small Cell Lung Carcinoma, Telomere. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Small cell lung cancer (SCLC) is an aggressive malignant disease with poor survival outcomes. The aim of this study was to investigate leukocyte telomere length (LTL) and redox status parameters during chemotherapy and evaluate their prognostic potential based on the hypothesis that shorter LTL and oxidative stress burden correlate with poorer survival. Materials and methods: This longitudinal study included 60 SCLC patients and 73 healthy controls. Leukocyte telomere length was measured by quantitative PCR (qPCR) method, while redox status parameters (MDA - malondialdehyde, IMA - ischemia-modified albumin, PON1 - paraoxonase 1, redox index) were determined by spectrophotometric methods before, after two and after four cycles of chemotherapy.

Results

All measured parameters showed significant differences between patients and controls, except the oxy-score (P < 0.001). Significant differences in IMA, PON1 and redox index were observed between SCLC patient groups at different time points (P < 0.001). Significant differences in IMA and PON1 were observed between SCLC survival groups, with higher values found in survivors after two chemotherapy cycles (P < 0.001). Redox index was the highest in the pre-chemo group (P = 0.019). Among patients who died, PON1 activity differed significantly between those who died within 2 months and after 4 months (P = 0.028). Kaplan-Meier analysis showed that LTL and PON1 were significant predictors of survival, with values below the 25th percentile associated with a higher risk of death.

Conclusions

Leukocyte telomere length and PON1 are potential prognostic biomarkers for SCLC survival, suggesting their potential use in non-invasive biomarker panels for improved patient stratification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oxidative StressLung NeoplasmsSmall Cell Lung CarcinomaTelomereTelomere HomeostasisHumansMaleFemaleMiddle AgedAgedAryldialkylphosphataseLongitudinal StudiesLeukocytesCase-Control StudiesAdultOxidation-ReductionPrognosis

Stichwörter der Autor:innen

cisplatin/etoposide regimenredox statussmall cell lung cancertelomere length

Substanzen

AryldialkylphosphatasePON1 protein, human

Autor:innen und Institutionen

  • Department for Medical Biochemistry, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia.
  • Internal Medicine Clinic "Akta Medica", Belgrade, Serbia.
  • Merck Sharp & Dohme d.o.o., Medical Affairs, Belgrade, Serbia.
  • Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
  • Clinic for Pulmonology, University Clinical Center of Serbia, Belgrade, Serbia.
  • Department of Clinical Biochemistry, Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.

Zitieren

APA

Guzonjić, A., Jovanović, D., Simić, I., Ćeriman Krstić, V., Samardzić, N., Ostanek, B., Marc, J., Sopić, M., & Kotur Stevuljević, J. (2025). Telomere length and oxidative stress in small cell lung cancer patients changes through chemotherapy cycles compared to healthy controls. Biochemia medica. https://doi.org/10.11613/bm.2025.020705

Vancouver

Guzonjić A, Jovanović D, Simić I, Ćeriman Krstić V, Samardzić N, Ostanek B, et al. Telomere length and oxidative stress in small cell lung cancer patients changes through chemotherapy cycles compared to healthy controls. Biochemia medica. 2025. doi:10.11613/bm.2025.020705

BibTeX
@article{Guzonji2025,
  author = {Guzonjić, Azra and Jovanović, Dragana and Simić, Ivana and Ćeriman Krstić, Vesna and Samardzić, Natalija and Ostanek, Barbara and Marc, Janja and Sopić, Miron and Kotur Stevuljević, Jelena},
  title = {Telomere length and oxidative stress in small cell lung cancer patients changes through chemotherapy cycles compared to healthy controls},
  journal = {Biochemia medica},
  year = {2025},
  doi = {10.11613/bm.2025.020705}
}
Kostenlos starten →